-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rintatolimod in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rintatolimod in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rintatolimod in Melanoma Drug Details: Ampligen is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rintatolimod in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rintatolimod in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rintatolimod in Metastatic Colorectal Cancer Drug Details: Ampligen is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rintatolimod in Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rintatolimod in Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rintatolimod in Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) Drug Details:...
-
Company Insights
Innovation and Patenting activity of CF Industries Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CF Industries Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Ammonia Industry Capacity and Capital Expenditure Forecasts with Details of Active and Planned Plants to 2028
Ammonia Industry Capacity & CapEx Overview The ammonia industry capacity was 240.38 million tonnes per annum (mtpa) in 2023 and will grow at an AAGR of more than 5% during 2023-2028. Around 113 planned and announced plants are scheduled to start operations by 2028, primarily in North America and FSU to meet the growing demand for nitrogen-based fertilizers in the agriculture industry. Additionally, the elevating cost of feedstock natural gas and the rise of end-users with decarbonization goals are factors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VAX-31 in Streptococcal Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAX-31 in Streptococcal Pneumonia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VAX-31 in Streptococcal Pneumonia Drug Details: VAX-XP is under development for the...
-
Thematic Analysis
Ammonia and Methanol in Energy Transition – Thematic Intelligence
Ammonia and Methanol in Energy Transition Thematic Report Overview Ammonia and methanol are key industrial chemicals with strong demand in the agriculture, manufacturing, and construction sectors. In 2022, the global ammonia and methanol production was 203 and 132 million metric tons, respectively. The demand for these chemicals is expected to rise in the coming years due to their potential applications in the energy transition. The ‘Ammonia and Methanol in Energy Transition’ thematic intelligence report discusses the sustainable approaches to ammonia...
-
Product Insights
External Remote Patient Monitoring Devices Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
External Remote Patient Monitoring Devices Pipeline Market Report Overview An External Remote Patient Monitoring Device retrieves the data from the external measurement device such as glucose meters. The device then transmits the data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The External Remote Patient Monitoring Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VAX-24 in Streptococcal Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAX-24 in Streptococcal Pneumonia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VAX-24 in Streptococcal Pneumonia Drug Details:VAX-24 is under development for the prevention of...